Chromosome 13q deletion mapping in pituitary tumors: Infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1562-1566

  Simpson, D J ^a   Magnay, J ^a   Bicknell, J E ^a   Barkan, A L ^b   McNicol, A M ^c   Clayton, R N ^a   Farrell, W E ^a,c,d  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME DELETION 13; CHROMOSOME MAP; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; PITUITARY NEOPLASMS; RETINOBLASTOMA PROTEIN;

EID: 0033119604     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alexander, J. M., Biller, B. M. K., Bikkal, H., Zervas, N. T., Arnold, A., and Klibanski, A. Clinically non-functioning pituitary tumors are monoclonal in origin. J. Clin. Invest., 86: 336-340, 1990.
2. Herman, V., Fagin, J., Gonsky, R., Kovaks, K., and Melmed, S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab., 71: 1427-1433, 1990.
3. Arnold, A. Molecular genetics of parathyroid eland neoplasia. J. Clin. Endocrinol. Metab., 77: 1108-1112, 1993.
4. Thakker, R. V. The molecular genetics of the multiple endocrine neoplasia syndrome. Clin. Endocrinol., 38: 1-14, 1993.
5. Melmed, S. Pituitary neoplasia. In: R. F. Gagel (ed.), Multiple Endocrine Neoplasia. Endocrinol. Metab. Clin. North Am., 23: 81-92, 1994.
6. Fearon, E. R., and Volgestein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
7. Jacks, T., Fazeli, A., Scmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. Effects of an RB mutation in the mouse. Nature (Lond.), 359: 295-300, 1992.
8. ΔD20/+ mice are predisposed to tumours of the pituitary gland with nearly complete penetrance. Oncogene, 9: 1021-1027, 1994.
9. Cryns, V. L., Alexander, J. M., Klibanski, A., and Arnold, A. The retinoblasloma gene in human pituitary tumours. J. Clin. Endocrinol. Metab., 77: 644-646, 1993.
10. Woloschak, M., Roberts, J. L. and Post, K. D. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer (Phila.), 74: 693-696, 1994.
11. Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Gilliland, D. G., and Black, P. M. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. Clin. Endocrinol. Metab., 78: 922-927, 1994.
12. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W. F., and Prager, D. Frequent loss of heterozygosity at the retinohlastoma susceptibility gene (RB) locus in aggressive pituitary tumours: evidence for a chromosome 13 tumour suppressor gene other than RB. Cancer Res., 55: 1613-1616, 1995.
13. Bates, A. S., Farrell, W. E., Bicknell, E. J., Talbot, A. J., Broome, J. C., Perrett, C. W., Thakker, R. V., and Clayton, R. N. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J. Clin. Endocrinol. Metab., 82: 818-824, 1997.
14. Yoo, G. H., Xu, H-J., Brennan, J. A., Westra, W., Hruban, R. H., Kock, W., Benedict, W. F., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
15. Borg, A., Zhang, Q. X., Alm, P., Olsson, H., and Selberg, G. The retinoblastoma gene in breast cancer: allelic loss is not correlated with loss of gene protein expression. Cancer Res., 52: 2991-2994, 1992.
16. Dodson, M. K., Cliby, W. A., Xu, H-J., Delacy, K. A., Hu, S-X., Keeney, G. L., Li, J., Podratz, K. C., Jenkins, R. B., and Benedict, W. F. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res., 54: 610-613, 1993.
17. Kim, T. M., Benedict, W. F., Xu, H-J., Hu, S-X., Gosewehr, J., Velicesu, M., Yin, E., Zheng, J., D'Ablaing, G., and Dubeau, L. Loss of heterozygosity on chromosome 13 is common only in biologically more aggressive subtypes of ovarian epithelial tumours and is associated with normal retinoblastoma gene expression. Cancer Res., 54: 605-609, 1994.
18. Cooney, K. A., Wetzel, J. C., Merajver, S. D., Macoska, J. A., Singleton, T. P., and Wojno, K. J. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 56: 1142-1145, 1996.
19. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localisation of a breast cancer susceptibility gene. BRCA2, to chromosome 13q12-13. Science (Washington DC). 265: 2088-2090, 1994.
20. Brown, A. G., Ross, F. M., Dunne, E. M., Steel, M., and Weir-Thompson, E. M. Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat. Genet., 3: 67-72, 1993.
21. Liu, Y., Szekely, L., Grander, D., Soderhall, S., Juliusson, G., Gahrton, G., Linder, S., and Einhorn, S. Chronic lymphocytic leukemia cells with allelic deletion at 13q14 commonly have one intact RB1 gene: evidence for a role of adjacent loci. Proc. Natl. Acad. Sci. USA, 90: 8696-8701, 1993.
22. Devilder, M. C., Francois, S., Bosic, A., Moreau, C., Mellerin, M. P., Le Paslier, D., Bataille, R., and Moisan, J. P. Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumour suppressor gene. Cancer Res., 55: 1355-1357, 1995.
23. Schott, D. R., Chang, J. N., Deng, G., Kurisu, W., Kuo, W. L., Gray, J., and Smith, H. S. A candidate tumour suppressor gene in human breast cancers. Cancer Res., 54: 1393-1396, 1994.
24. Farrell, W. E., Simpson, D., Bates, A. S., Talbot, J. A., Bicknell, J., and Clayton, R. N. Chromosome 9p deletions in invasive and non invasive non-functional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 gene. Cancer Res., 57: 2703-2709, 1997.
25. Hardy, J. Transphenoidal microsurgical treatment of pituitary tumours. In: J. Linfoot (ed.), Recent Advances in the Diagnosis and Treatment of Pituitary Tumours, pp. 375-388. New York: Raven Press, 1979.
26. Toguchida, J., Mcgee, T. L., Paterson, J. C., Eagle, J. R., Tucker, S., Yandell, D. W., and Dryja, T. P. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics, 17: 535-543, 1993.
27. Chapman, R. M., Corcoran, M. M., Gardiner, A., Hawthorn, L. A., Cowell, J. K., and Oscier, D. G. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene, 9: 1289-1293, 1994.
28. Melemed, J., Einhorn, J. M., and Ittmann, M. M. Allelic loss on chromosome 13q in human prostate carcinoma. Clin. Cancer Res., 3: 1867-1872, 1997.
29. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, E., Skogseid, B., et al. Localisation of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumours. Proc. Natl. Acad. Sci. USA, 87: 1968-1972, 1990.
30. Thakker, R. V., Pook, M. A., Wooding, C., Boscaro, M., Scanarini, M., and Clayton, R. N. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J. Clin. Invest., 91: 2815-2821, 1993.
31. Boggild, M. D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., Mcternan, P., Perrett, C. W., Thakker, R. V., and Clayton, R. N. Molecular genetic studies of sporadic pituitary tumours. J. Clin. Endocrinol. Metab., 78: 387-392, 1994.
32. Simpson, D. J., Bicknell, E. J., McNicol, A. M., Clayton, R. N., and Farrell, W. E. Hypermethylation of the p1b/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but somatotrophinomas. Genes Chromosomes Cancer, 24: 328-336, 1999.
33. Woloschak, M., Yu, A., Xiao, J., and Post, K. D. Abundance and state of phosphorylation of the relinoblastoma gene product in human pituitary tumours. Int. J. Cancer, 67: 16-19, 1996.
34. Lucke, M., Hamel, W., Ludecke, D. K., Hermann, H. D., and Westphal, M. Expression of retinoblastoma gene in human intracranial neoplasms. Int. J. Oncol., 4: 885-890, 1994.
35. Hinton, D. R., Hahn, J. A., Weiss, M. H., and Couldwell, W. T. Loss of RB expression in an ACTH-secreting pituitary carcinoma. Cancer Lett., 126: 209-214, 1998.